4123.TWO
4123.TWO
TW0004123005
CENTER LABORATORIES INC
Loading chart...

Company Profile

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.

Related stocks

4105.TWO
4105.TWO • Taiwan
TTY BIOPHARM COMPANY LIMITED
80.9 TWD
630.39M USD 1Y +0.6%
300194.SZ
300194.SZ • China
FUAN PHARM
4.03 CNY
717.42M USD 1Y -7.8%
9989.HK
9989.HK • China
HEPALINK
4.03 HKD
752.61M USD 1Y -26.6%
AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%
6472.TW
6472.TW • Taiwan
BORA PHARMACEUTICALS CO LTD
421 TWD
1.68B USD 1Y -36%
002793.SZ
002793.SZ • China
LUOXINPHARMACEUTICAL
4.89 CNY
795.8M USD 1Y -0.2%
185750.KS
185750.KS • South Korea
CHONGKUNDANG
65,900 KRW
647.98M USD 1Y -19.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
29.0% p.a.
Max Drawdown (5Y)
-48.3%
Sharpe Ratio (5Y)
-0.27
Beta Factor
0.25
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 84.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (29.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -61.0% in the extended horizon.
ende